DISCOVER A DEEPER YOU Trademark

Trademark Overview


On Tuesday, January 10, 2017, a trademark application was filed for DISCOVER A DEEPER YOU with the United States Patent and Trademark Office. The USPTO has given the DISCOVER A DEEPER YOU trademark a serial number of 87295178. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 25, 2019. This trademark is owned by PathoBiome LLC. The DISCOVER A DEEPER YOU trademark is filed in the Pharmaceutical Products category with the following description:

Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liqu...
discover a deeper you

General Information


Serial Number87295178
Word MarkDISCOVER A DEEPER YOU
Filing DateTuesday, January 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements


Goods and ServicesProbiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; nutritional supplements, namely, probiotic compositions; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as crohn's disease, ulcerative colitis and irritable bowel syndrome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePathoBiome LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCleveland, OH 44115

Party NamePathoBiome LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCleveland, OH 44115

Trademark Events


Event DateEvent Description
Monday, February 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2018EXTENSION 1 GRANTED
Friday, July 20, 2018EXTENSION 1 FILED
Friday, July 20, 2018TEAS EXTENSION RECEIVED
Tuesday, January 23, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2017NON-FINAL ACTION E-MAILED
Monday, March 27, 2017NON-FINAL ACTION WRITTEN
Tuesday, March 21, 2017ASSIGNED TO EXAMINER
Tuesday, January 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM